Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.